Alpha Tau Medical Ltd. - Ordinary Shares (DRTS)
NASDAQ · Healthcare
$13.47-0.59%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.22B
- P/E ratio
- —
- EPS
- —
- Volume
- 618,874
- 52-week high
- —
- 52-week low
- —
- Open
- $13.55
- Day high
- $13.89
- Day low
- $13.20
Financial highlights
Annual financials for Alpha Tau Medical Ltd. - Ordinary Shares are being compiled and will appear here soon.
About Alpha Tau Medical Ltd. - Ordinary Shares
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
- CEO
- Uzi Sofer
- Employees
- 121
- Country
- IL
- IPO date
- Mar 8, 2021
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Alpha Tau Medical Ltd. - Ordinary Shares's stock price today?
- DRTS is trading at $13.47 as of Jul 20, 2026.
- What is Alpha Tau Medical Ltd. - Ordinary Shares's market cap?
- Alpha Tau Medical Ltd. - Ordinary Shares (DRTS) has a market capitalization of $1.22B.
- What sector is Alpha Tau Medical Ltd. - Ordinary Shares in?
- Alpha Tau Medical Ltd. - Ordinary Shares operates in the Healthcare sector.